CP-465,022, a Selective Noncompetitive AMPA Receptor Antagonist, Blocks AMPA Receptors but Is Not Neuroprotective in Vivo

Stroke - United States
doi 10.1161/01.str.0000048216.90221.9c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Water Soluble RNA Based Antagonist of AMPA Receptors

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2007English

Philanthotoxin Blocks Quisqualate-, AMPA- And Kainate-, but Not NMDA-, Induced Excitation of Rat Brainstem Neurones in Vivo

British Journal of Pharmacology
Pharmacology
1990English

Association of AMPA Receptors With a Subset of Glutamate Receptor-Interacting ProteinIn Vivo

Journal of Neuroscience
Neuroscience
1999English

Resensitizing AMPA Receptors

Journal of General Physiology
Physiology
2019English

PICK1 Mediates Transient Synaptic Expression of GluA2-Lacking AMPA Receptors During Glycine-Induced AMPA Receptor Trafficking

Journal of Neuroscience
Neuroscience
2012English

The Transmembrane AMPA Receptor Regulatory Protein 4 Is a More Effective Modulator of AMPA Receptor Function Than Stargazin ( 2)

Journal of Neuroscience
Neuroscience
2007English

The Neuroprotective Effect of the Novel AMPA Receptor Antagonist PD152247 (PNQX) in Temporary Focal Ischemia in the Rat Editorial Comment

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1999English

AMPA Receptor Antagonist Perampanel Affects Glioblastoma Cell Growth and Glutamate Release in Vitro

PLoS ONE
Multidisciplinary
2019English

AMPA Receptor Activation Causes Silencing of AMPA Receptor-Mediated Synaptic Transmission in the Developing Hippocampus

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy